Analyzing Nexentis Technologies (NXTS) & Its Competitors

Nexentis Technologies (NASDAQ:NXTS) is one of 896 public companies in the “Pharmaceuticals” industry, but how does it weigh in compared to its rivals? We will compare Nexentis Technologies to similar businesses based on the strength of its profitability, valuation, institutional ownership, earnings, dividends, risk and analyst recommendations.

Risk & Volatility

Nexentis Technologies has a beta of 1.95, meaning that its share price is 95% more volatile than the S&P 500. Comparatively, Nexentis Technologies’ rivals have a beta of -3.79, meaning that their average share price is 479% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Nexentis Technologies and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexentis Technologies	1	0	0	0	1.00
Nexentis Technologies Competitors	7806	13897	25803	1039	2.41

As a group, “Pharmaceuticals” companies have a potential upside of 25.42%. Given Nexentis Technologies’ rivals stronger consensus rating and higher probable upside, analysts clearly believe Nexentis Technologies has less favorable growth aspects than its rivals.

Institutional and Insider Ownership

61.2% of Nexentis Technologies shares are held by institutional investors. Comparatively, 32.6% of shares of all “Pharmaceuticals” companies are held by institutional investors. 6.5% of Nexentis Technologies shares are held by insiders. Comparatively, 14.2% of shares of all “Pharmaceuticals” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Nexentis Technologies and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexentis Technologies	N/A	-304.79%	-178.91%
Nexentis Technologies Competitors	-2,380.61%	-219.90%	-15.56%

Valuation & Earnings

This table compares Nexentis Technologies and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Nexentis Technologies	$210,000.00	-$4.00 million	-0.03
Nexentis Technologies Competitors	$3.54 billion	$3.18 billion	552.64

Nexentis Technologies’ rivals have higher revenue and earnings than Nexentis Technologies. Nexentis Technologies is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

Nexentis Technologies rivals beat Nexentis Technologies on 10 of the 13 factors compared.

About Nexentis Technologies

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company’s products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens.